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ABSTRACT 
Background: Polyphenols are macromolecules that play a pivotal role in 
plant protection against external aggression from microorganisms or 
radiations. Their antimicrobial properties have raised interest in the 
medical community for several years now. Among them, tannic acid is one 
of the cheapest polyphenols extracted from plants. However, its broad use 
is impeded because it is unstable, with rapid hydrolysis leading to 
byproducts such as epigallocatechin with less activity. In this work, we 
developed a porous material to deliver locally tannic acid. 
Methods: The preparation of this matrix relied on the interaction between 
gelatin and tannic acid in an aqueous medium. Structure properties of the 
developed matrix were investigated through rheology measurement and 
by scanning electron microscopy (SEM). Tannic acid quantity and release 
over time were measured. Antimicrobial activity was tested in vitro on 
E. coli and S. aureus. 
Results: The presence of two tannic acid populations, one free to diffuse 
across the scaffold and the second stabilized by gelatin with a more 
structural activity, was demonstrated. We showed that the formulation is 
possible above a molar ratio of 1:15 (gelatin:tannic acid). Gelatin was used 
here as a carrier for the tannic acid. Tannic acid content could be 
modulated depending on its initial concentration during the preparation. 
Tannic acid was released from these matrices over a period of four days 
at a concentration that was above the minimum inhibitory concentration 
(MIC). Antimicrobial activity was confirmed on E. coli and S. aureus. The 
porous material could be conserved by lyophilization without loss of 
activity. Its handiness is good enough to consider its use as a wound 
dressing.  
Conclusions: We demonstrate herein an easy and cost-effective protocol to 
locally deliver tannic acid. 
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INTRODUCTION 
Polyphenols are macromolecules that play a pivotal role in plant 
protection against external aggression from microorganisms or radiations 
[1]. The family is broad with epigallocatechin, gallic acid derivatives, 
tannins, flavonoids, isoflavonoids, and anthocyanins to cite only a few. 
Their activity against bacteria, viruses, and fungi have raised interest in 
their use in medicine. Additional functionalities such as their 
antioxidative properties and anti-cancer activity, which have been studied 
previously, help to motivate the research on their use in clinical 
applications. While polyphenols are available by the simple consumption 
of fruits, vegetables, and wine or coffee, many efforts have been put into 
their isolation and presentation to be readily used in the clinic under other 
forms. Polyphenols of various origins have been incorporated into various 
materials, usually without real isolation of the active compound. For 
example, Talón et al. incorporated pea starch and thyme extract into 
chitosan sponges for their antioxidant activity [2]. The isolation of 
polyphenols can be time consuming and expensive, making them poor 
candidates for materials formulation. Among them, tannic acid is of 
particular interest. It is readily available and cheap. It presents good 
antimicrobial activity on several bacteria and antioxidant properties. 
However, it is quite unstable with a rapid degradation into smaller 
macromolecules such as gallic acid in an oxidative environment. Its 
oxidation tends to diminish its potential as an antimicrobial agent. It can 
also be cytotoxic depending on its concentration. Hence, it has to be 
delivered at a concentration high enough for antimicrobial activity but 
low enough to avoid a deleterious effect on tissues. Research on the 
controlled release of tannic acid is of great importance. Up to now, few 
examples of materials incorporating tannic acid and intended for 
controlled release have been published. Lu et al. prepared chitosan–
gelatin sponges loaded with tannins and platelet-rich plasma as a wound 
dressing to activate wound healing. Tannic acid plays a role in crosslinking 
the sponge and to some extent added antimicrobial properties [3]. Guo et 
al. developed a gelatin/TA sponge crosslinked with AgNO3 as a bioadhesive 
with antimicrobial properties [4]. TA is known to interact strongly with 
gelatin, mostly via the proline residues of the protein [5]. Other strategies 
aimed at grafting of tannic acid via their hydroxyl groups onto the 
carboxyl group of polymers via esterification methods to produce 
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poly(methacrylic acid) microparticles releasing TA for more than 40 h [6]. 
Tannic acid-based particles were successfully produced from the macro- 
to nanosize range. Such particles incorporated in porous poly(HEMA) 
cryogels helped to add antimicrobial properties to this future wound 
dressing material [7]. Apart from its biological properties, tannins in 
general and tannic acid in particular are well known for their interactions 
with proteins. They strongly interact with proteins via hydrogen bonds. 
This explains why their use in the leather industry was so prominent. It 
can be used as a crosslinking agent to stabilize nanoparticles or scaffolds. 
However, its use has to be modulated to insure the functionality of the 
materials. Indeed, by depositing tannic acid and alkaline phosphatase on 
substrates layer-by-layer, we previously showed that alkaline phosphatase 
was inactivated when the concentration of tannic acid was increased [8].  
In this study, we developed a method for the local delivery of tannic 
acid using gelatin (G) as a carrier. It resulted in a material that could be 
used for example as a wound dressing. Tannic acid was used both for the 
shaping of the gelatin matrix and as a therapeutic agent. The preparation 
process relied on the interaction of tannic acid with the protein to form a 
precipitate when raise above a threshold in the tannic acid:gelatin molar 
ratio. We showed that these matrices after crosslinking with 
formaldehyde can be manipulated and are stable up to seven days. More 
interestingly, the designed matrices showed a slow release of tannic acid. 
Such wound dressing materials present a good antimicrobial activity. 
Their conservation was ensured by lyophilization.  
MATERIALS AND METHODS 
Materials 
Tannic acid (CAS number 1401-55-4, ref 403040-500G), gelatin type A 
with an isoelectric point close to 9 (Gelatin from porcin skin CAS number 
90000-70-8, ref 1890-1009), citric acid (CAS number 77-92-9, ref 251275), 
sodium phosphate dibasic (CAS number 7558-79-4, ref S7907), and Luria 
Bertani broth (ref L3022) were purchased from Sigma-Aldrich (St. Louis, 
MI, USA). Mueller–Hinton Broth (BDTMDIFCOTM, ref BD 275710) and 
Mueller–Hinton gelose (BDTMDIFCOTM, ref BD 214530) were purchased 
from Fisher Scientific (Hampton, NH, USA). 
G/TA Matrix Preparation 
All preparations were made in a citrate/phosphate buffer at pH = 7.00 
to work in close physiological conditions. Citrate/phosphate buffer was 
prepared by mixing 65.88 mL of Na2HPO4 0.5 M solution, 7.06 mL citric 
acid 0.5 M solution, and 127.1 mL of MilliQ water. TA and gelatin solutions 
were prepared just before the TA/gelatin matrix preparation. The TA 
solutions were prepared at various concentrations depending on the 
TA:gelatin molar ratio by dissolving TA powder in citrate/phosphate buffer 
and stirring for 1 h to ensure the complete dissolution of TA. The solubility 
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of tannic acid in water is 100 mg·mL−1 at ambient temperature. TA has an 
isoelectric point close to 8.5 [9] and is hence non-charged in the 
experimental conditions where the TA/gelatin blends were prepared. The 
gelatin solutions were prepared at 2 or 10 mg/mL depending on the size of 
the matrix prepared. Gelatin solutions were heated at 37 °C to ensure 
complete dissolution. Once dissolved, the gelatin solution was cooled to 
room temperature before use. G/TA matrices were prepared by mixing 
equal volumes of TA and gelatin solutions followed by 30 s of vortexing. 
The obtained solution was poured in a mold or in a well of a multiwell 
plate and centrifuged at 1200 rpm for 15 min in a plate centrifuge (Allegra 
X-15R centrifuge, rotor SX4750, Beckman Coulter). The supernatant was 
discarded and replaced by an equal volume of paraformaldehyde (PFA) 4% 
solution in citrate/phosphate buffer at pH = 7.00. G/TA matrices were 
incubated for 24 h at room temperature. The PFA solution was then 
discarded and the matrix rinsed three times with an equal volume of 
citrate/phosphate buffer at pH = 7.00 for at least 15 min each. The obtained 
matrices were used directly or lyophilized. Before lyophilization, the 
matrices were frozen at −80 °C for at least 3 h. Lyophilization was then 
performed with a CHRIST Alpha 1-4 LD plus lyophilizator (Martin Christ 
Freeze Dryers GMBH, Osterode am Harz, Germany), for 24 h at −56 °C and 
0.5 mBar. Lyophilized G/TA matrices were kept at room temperature and 
protected against moisture before use. G/TA matrices were prepared at 
different molar ratios and are described as G/TAx, with x corresponding to 
the ratio of TA compared to gelatin. As gelatin is polydisperse, its average 
molecular weight of 80 kDa, as indicated by the furnisher, was used for the 
calculations.  
G/TA Matrix Characterization 
Scanning electron microscopy 
G/TAx matrices were first lyophilized as described above. They were 
then sectioned in the middle and fixed on a holder to allow imaging their 
cross section or their surface. The G/TAx matrices were then coated with a 
gold–palladium alloy using a Hummer JR sputtering device (Technics, CA, 
USA). Scanning electron microscopy was then performed with a Quanta 
250 ESEM (FEI Company, Eindhoven, The Netherlands) with an 
accelerating voltage of the electrons of 5 kV. 
TA adsorption isotherm 
G/TAx matrices were prepared at various molar ratios of TA, ranging 
from 1:15 to 1:100, with a constant concentration of gelatin (2 mg/mL). For 
each molar ratio, the TA content in the matrix formed was measured. This 
measurement was performed by means of a solution depletion method. 
After completion of the centrifugation step (cf. Section “G/TA Matrix 
Preparation”), the TA content (in mg) of the supernatant was measured 
by UV-Visible spectroscopy at λ = 277 nm with a SAFAS mc² 
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spectrophotometer (Xenius, SAFAS, Monaco). At this wavelength, gelatin 
that is devoid of L-tyrosine, L-phenylalanine, and L-tryptophan residues 
does not absorb light. This allows quantification of TA without 
interference from the protein. Measurement was done on 100 µL solution 
transferred into a 96-well plate (UV star, ref 655801, Greiner Bio-One). TA 
concentration in the supernatant was calculated from the OD 
measurement using a calibration curve performed in the same conditions. 
The TA content in the matrix (TAm), in mg, was calculated with Equation (1) 
TAm = TA0 − TAs,         (1) 
where TA0 is the quantity of tannic acid used during the matrix 
preparation and TAs is the quantity of TA measured in the supernatant 
after completion of the centrifugation. TAm was plotted as a function of TA0 
to get an adsorption isotherm.  
Rheology 
Oscillatory amplitude shear experiments were performed on a Kinexus 
Rheometer (Malvern Instruments Ltd., MA, USA). Cylinder-shaped 
gelatin/tannic acid matrices with 34 mm diameter and 4 mm thick were 
prepared on a circular silicon sheet. Frequency sweep measurements 
were performed at 10 Hz, which is in the region of linear response 
determined previously by sweep frequency measurement. Measurement 
were performed with a cone–plate geometry with a cone size of 4 cm and 
an angle of 4°. 
Measurement of Tannic Acid Release from the G/TA Matrices 
Tannic acid release from the matrices was measured by UV-Visible 
spectroscopy. After preparation of the G/TAx matrices, they were 
incubated at room temperature in citrate/phosphate buffer at pH = 7.00. 
The release of TA was measured in the buffer supernatant at various time 
points. One hundred microliters were withdrawn, and the absorbance 
measured at λ = 277 nm with a SAFAS mc² spectrophotometer. 
Measurements were performed in a 96-well plate (UV star, ref 655801, 
Greiner Bio-One). The amount of released tannic acid was calculated from 
a calibration curve performed in the same conditions. At each time point 
measured, the buffer was completely withdrawn and replaced by fresh 
one. The results are expressed as a cumulative release.  
Antimicrobial Activity 
Bacteria 
Staphylococcus aureus (S. aureus, ATCC 25923) and Escherichia coli (E. 
coli, ATCC 25922) microorganisms were cultured according to the 
manufacturer’s instructions in their respective media: Luria Bertani broth 
was used for E. coli, while Mueller–Hinton broth (MHB) was used for S. 
aureus. 
 
Pharmaceutical Frontiers 6 of 16 
Pharm Front. 2020;2:e200002. https://doi.org/10.20900/pf20200002 
Antimicrobial activity measurement 
Agar diffusion assay 
The bacteriostatic effect of tannic acid was evaluated by the agar 
diffusion assay [10]. The inoculum used for this experiment was prepared 
using an overnight culture of S. aureus or E. coli in MH broth. The turbidity 
was adjusted to a 0.5 McFarland. This well diffusion test was performed 
using three identical series, distributed in two Petri dishes containing 
25 mL of Mueller–Hinton broth and bacteriological agar. Nine wells, 3 mm 
in diameter, were cut out of the agar. One hundred microliters of bacteria 
suspension were spread homogeneously over each agar petri dish. Forty 
microliters of TA solution (10, 5, 2, 1, 0.8, 0.6, 0.4, 0.2, and 0.1 mg/mL) were 
placed into each well. The Petri dishes were incubated at 37 °C for 24 h. 
Diffusion distances were determined as half the inhibition zone diameter 
minus the well diameter. Petri dishes were analyzed individually to 
determine the minimum inhibitory concentration (MIC) and the average 
values from three repeats were taken for the determination of the final 
MIC. MIC was calculated using a model based on a generalized diffusion 
equation that includes a dissipative term [10]. 
Growth inhibition in planktonic culture 
Antimicrobial activity measurements were performed on matrices 
prepared in 48-well plates from 1 mg of gelatin. Bacterial strains were 
cultured aerobically at 37 °C in a Mueller–Hinton broth (MHB) at pH 7.4. 
One colony was transferred to 10 mL of MHB medium and incubated at 
37 °C for 20 h. Five hundred microliters of bacterial solution, representing 
4.105 CFU, were added to each well. Plates were then incubated for 24 h at 
37 °C under constant stirring. After completion of the incubation period, 
100 µL of medium was withdrawn and transferred into a 96-well plate. The 
absorbance at λ = 600 nm was then recorded using a Multiskan EX 
microplate spectrophotometer (ThermoFisher Scientific) to quantify 
bacterial growth. Percentage of growth was expressed regarding the 
positive control represented by an empty well.  
RESULTS 
G/TAx Matrix Characterization 
G/TAx matrices were prepared based on the protocol described in 
Figure 1. A rapid mixing of TA and gelatin solution leads to gelatin 
precipitation that can be easily centrifuged to form a matrix.  
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Figure 1. G/TAx matrices preparation: (1) Gelatin solution in citrate/phosphate buffer at pH = 7.00 and tannic 
acid solution in citrate/phosphate buffer at pH = 7.00 are mixed at equal volume. (2) G/TA blends are 
thoroughly mixed for 30 s (3), and then dispensed into a suitable container and centrifuged for 15 min at 
1200 rpm (4). (5) G/TAx matrices are incubated in PFA 4% solution in citrate/phosphate buffer at pH = 7.00 
for 24 h at room temperature. After three rinsing steps, the matrices are lyophilized (6). 
Both the quantity of gelatin used and the shape of the mold determine 
the size and shape of the matrix. We crosslinked the matrix after it was 
centrifuged to stabilize it. Indeed, protein–tannic acid interactions are 
non-covalent, mainly hydrogen bond and hydrophobic interactions, and 
can be destabilized by several parameters such as pH or osmotic pressure. 
The range of molar ratios tested was from 1:15 to 1:200.  
Scanning electron microscopy micrographs of the matrix after 
lyophilization showed that the obtained matrix is porous. The pores seem 
to be interconnected. However, more interestingly, the walls of the matrix 
show a granular aspect at high magnification (60,000×) (Figure 2).  
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Figure 2. SEM micrograph of a G/TA70 at: 200× (A); 2000× (B); and 60,000× (C). Observations were performed 
on the surface of the matrix (left) or on the section (right). Scale bar = 100 mm (A) and 1 mm (B,C). 
The effect of the crosslinking step on the matrix was assessed by 
measuring the rheological properties of the matrix as a function of time. 
As shown in Figure 3, we measured an increase of the storage (G’) and loss 
(G’’) moduli with time from the beginning of the crosslinking process. After 
2 h, those two parameters remained stable.  
 
Figure 3. Evolution of G’ and G’’ during the crosslinking process. The data correspond to the average over 
three measurements and the error bars correspond to ±1 standard deviation. 
These results were confirmed by the evaluation of the compressive 
modulus before and after crosslinking. The compressive modulus 
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increased from 46 ± 4 to 350 ± 50 kPa upon crosslinking. This showed that 
the crosslinking of the gelatin molecules with PFA was effective and 
changed the overall physical properties of the matrix. Measurement of the 
compressive modulus did not show any difference between Day 0 and Day 
7 of storage in citrate/phosphate buffer at pH = 7.00 (data not shown). The 
water content of G/TA100 and G/TA150 matrices corresponded to 84 ± 5% of 
the mass of the matrix, as determined by weighing the hydrated and dried 
samples. 
As we consider gelatin as a TA carrier, we evaluated the quantity of 
polyphenol held by gelatin as a function of the initial tannic acid 
concentration. The obtained results are presented in Figure 4. In the range 
of tested concentrations, we did not observe saturation of the adsorption 
isotherm with a visible plateau. TA concentration can therefore be tuned 
by adjusting the TA concentration during the formation of the matrices.  
 
Figure 4. Measure of the tannic acid content in G/TAx as a function of the initial concentration of tannic acid 
used during the formulation process for a fixed concentration of gelatin at 1 mg/mL. The data correspond 
to the average over three independent measurements and the error bars to ±1 standard deviation. 
The release of TA was measured at various time points during four 
consecutive days. The results are presented as cumulative tannic acid 
release in Figure 5A as amount per mg of gelatin or in percentage of initial 
tannic acid content (see Supplementary Figure S1). The point at Day 1 
represents the tannic acid release during the crosslinking step. The point 
at Day 1.5 represents the concentration of tannic acid that is released 
during the rinsing step that insured PFA elimination. Days 2–4 represent 
the release in the conditions of use. For each G/TAx composition, we 
observed a release over the time course of the experiment. This release 
depended on the concentration of tannic acid used during the formulation 
of the matrix, with a more important release for G/TA200 than for G/TA15. 
For all tested TA concentrations, we observed a pronounced release at 
Day 1 that represents the diffusion of unbound TA out of the matrix. At 
Days 2–4 we still observed a TA release but at a slower rate: between 40 
and 2 µg for a matrix made from 1 mg of gelatin.  
 
Pharmaceutical Frontiers 10 of 16 
Pharm Front. 2020;2:e200002. https://doi.org/10.20900/pf20200002 
  
Figure 5. Tannic acid release from G/TAx matrices over the time: (A) amount of tannic acid delivered from 
a G/TAx matrix made from 1 mg gelatin; and (B) amount of tannic acid in the G/TAx matrix left over the time 
in mg ± SE. (◇) G/TA15; (○) G/TA30; (☐) G/TA50; (▲) G/TA70; (◆) G/TA100; (●) G/TA150; and (◼) G/TA200. 
The quantities of TA remaining in the G/TA200, G/TA150, G/TA100, G/TA70, 
and G/TA50 matrices were observed to be nearly the same. This quantity, 
about 200–250 µg, was greater than the available TA amount in G/TA30 
(125 mg) and G/TA15 (33 mg) (Figure 5B). Statistical analysis (p < 0.05, 
ANOVA) showed that the amount of released tannic acid was lower for the 
matrices prepared with lower molar ratios of polyphenol (G/TA15 and 
G/TA30). Such a finding suggests that, above a molar ratio of 1:50, the 
quantity of tannic acid is such that not all the available polyphenol 
molecules can interact strongly with gelatin and are therefore released.  
Antimicrobial Properties of the G/TAX Matrices 
We first determined the antimicrobial properties of tannic acid on the 
two bacterial strains of interest: S. aureus (Gram+) and E. coli. (Gram−). 
Those two bacterial strains are involved in diverse diseases with different 
clinical expression and are of concern in nosocomial infections. Agar 
diffusion assays allowed determining the MIC at 105 mg/mL for E. coli and 
100 mg/mL for S. aureus. 
Then, we determined the antimicrobial activity of G/TA matrices made 
with 0.3 mg of gelatine (Figure 6). Over this 24 h experiment, we recorded 
that the inhibition of bacterial growth depended on the matrices and the 
bacterial strain tested. For E. coli, a complete growth inhibition was 
observed with G/TA70, G/TA100, G/TA150, and G/TA200. Growth inhibition 
increased with the increase of the molar ratio (G/TA15 < G/TA30 < G/TA50). 
The same behavior was recorded for S. aureus. For the same molar ratio, 
we recorded a better growth inhibition of G/TA15, G/TA30, and G/TA50 for S. 
aureus than for E. coli with more than 90% inhibition. 
Finally, as we are aware that tannic acid, a hydrolysable polyphenol, is 
not stable in oxidative conditions, we tested the effect of lyophilization on 
the antimicrobial properties of the G/TA matrices. G/TA70 matrices were 
prepared as before but followed by a lyophilization process. Before their 
use, they were kept in dry conditions and protected from light. Their 
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antimicrobial activity was tested as before. At 24 h, growth inhibition on 
E. coli was the same as previously recorded with fresh G/TA70 matrices 
(Figure 6 inset). 
 
Figure 6. Evaluation of bacterial growth of E. coli (dashed bars) and S. aureus (plain bars) in presence of 
G/TAx matrices. Percentage of growth was determined and compared to normal growth in the same media 
but without matrix. (Inset) Evaluation of inhibition growth on E. coli of G/TA70 matrix after lyophilization. 
DISCUSSION 
We succeeded in preparing gelatin/tannic acid matrices that represent 
a cost effective and easy way to produce a tannic acid delivery system. Our 
strategy was based on the natural interaction of tannic acid with proteins 
through hydrogen bonds and hydrophobic interactions. With such a 
method, we were able to produce matrices with gelatin concentration that 
do not allow gel formation, such as 1% w/v solutions [11]. As the 
interaction between gelatin and tannic acid relies on non-covalent binding, 
we can expect, depending on the pH and ionic strength, for example, the 
release of non-strongly-bound TA [12]. The process seems to be overly 
simple but different parameters have to be taken into account such as pH 
and ionic strength because they can affect the interaction between both 
components and therefore the structuration of the matrix and the release 
of tannic acid. First, not only hydrogen bonding takes place, but, according 
to some other studies, hydrophobic and electrostatic interactions also 
occur. At pH = 7.00, lower than the pKa value of tannic acid, electrostatic 
interactions are possible with the negatively charged gelatin of type A 
(pHi = 9). However, the ionic strength has to be close to physiological value. 
Indeed, when ionic strength increases, gelatin takes a more compact 
conformation due to internal charge screening. It avoids interchain 
repulsion and favors the interaction with tannic acid [13]. Hydrophobic 
bonding occurs between L-proline in gelatin and the phenolic group in 
tannic acid. This interaction mode could generate some cavities in the 
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materials, similar to what was observed in the construction of 
gelatin/tannic acid multilayer films [13]. Overall, all these weak 
interactions have the potential to generate macromolecules mobility. In 
our case, we observed a modification of the area of our matrices over time 
(Supplementary Figure S2) with a diminution of 10% after four days in 
buffer at pH = 7.00 and 35% after 23 days. It shows that the system is not 
at equilibrium once produced. We observed that the shrinking of the 
matrix is dependent on the medium, being more pronounced in DMEM, a 
cell culture media, than in citrate/phosphate buffer. It suggests that the 
interactions undergone by gelatin are influenced by the nature and 
concentration of the present electrolytes, as observed in the literature [14]. 
It has been demonstrated that the interaction of tannic acid with 
protein is also dependent on its concentration. Under the critical micellar 
concentration (CMC), the interaction is specific, and we can find few tannic 
acid molecules interacting with proteins. Above the CMC, tannic acid form 
aggregates and interaction with proteins are less specific. The interaction 
of tannic acid aggregates can be done with different protein in their 
surrounding media. Large TA–protein aggregates can be formed [15]. In 
our case, the concentration of tannic acid was always above the CMC of 
tannic acid (3.10 × 10−4 mol/L, i.e., 0.53 mg/mL) [15]. We thus produced 
large aggregates that could be centrifuged to prepare the material in the 
form of a pellet. This also explains the porous aspect of the matrix, as 
found at high magnification in SEM.  
We observed a release of tannic acid over time from each formulation. 
Such a release was observed during about four days with an initial burst 
release lasting 24 h followed by a slower release up to four days. 
Considering the quantity of tannic acid left in the matrices after four days, 
we observed that all matrices made from a molar ratio above 50 between 
TA and gelatin led to the same amount remaining in the matrix. Hence, 
above a molar ratio of 50, there are two tannic acid populations: one can 
be considered as strongly bound to gelatin and the other considered as 
mobile. Below this threshold value, TA release was minimal. The tannic 
acid released over time was therefore present in the water content of the 
matrices or resulted from tannic acid aggregates that disassembled. In fact, 
TA spontaneously forms solution aggregates at high concentrations [16]. 
From a practical point of view, using gelatin as a binder for tannic acid 
implies using molar ratios above 50. Otherwise, we cannot have two 
populations of tannic acid; only the “structural” one is available with no 
diffusible molecules. The increase of the G:TA molar ratio allows an 
increase in polyphenol release.  
To help the handling of the matrix by hand or with tweezers 
(Supplementary Video S1), a crosslinking step was added in the 
formulation by the use of paraformaldehyde. This crosslinking step 
increased the mechanical properties, as demonstrated by compressive 
modulus testing. Paraformaldehyde is a well-known protein crosslinker 
[17]. However, at first glance, it could appear impractical to use it for 
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biomaterials, as the toxicity of paraformaldehyde is potent. Formaldehyde 
and glutaraldehyde are already used in pig cardiac valve preparation. In 
that preparation, the action on the protein helps to reduce the immune 
response to the grafts [18,19]. No toxicity has been recorded thus far with 
the use of these bioprosthesis. Use of other crosslinking agents that are 
more biocompatible could be of interest, such as genepin [20]. The 
formaldehyde crosslinking is not stable. Temperature will affect the half-
life of the reaction. At 37 °C, the half-life of formaldehyde protein–DNA 
crosslinks was measured to be about 22 h [21]. Thus, after several days, we 
can expect that some of the gelatin–gelatin crosslinks no longer persist. 
TA is also reported as a crosslinking agent [5,22,23]. It could help the 
overall structuration of the scaffold. Researchers using tannic as a 
crosslinker tend to use far lower TA:protein ratios than what we did in this 
study. At pH = 8.00, covalent binding between tannic acid and gelatin can 
occur between the amine group of gelatin (lysine, arginine, and histidine 
residues) and the oxidized phenolic group of tannic acid [24]. However, at 
this pH, oxidation can occur rapidly and would diminish the antimicrobial 
activity, which is why we decided to work at a controlled pH = 7.00. Our 
matrices remained stable for at least 23 days. 
Use of tannic acid as an antimicrobial agent tends to be tricky because 
of its instability. Indeed, under oxidative environment, it degrades into 
smaller molecular weight products by hydrolysis [25]. Such byproducts 
lose their antimicrobial properties. In our matrices, oxidation of the tannic 
acid could be easily seen by a color change from a yellowish color to dark 
green. The same observation can be made when oxidation is triggered by 
sodium periodate [8]. For this reason, we tested the antimicrobial activity 
after lyophilization of the matrix. Indeed, once lyophilized, tannic acid can 
be conserved for a longer period of time. No loss in antimicrobial activity 
was recorded with such preparation.  
Tannic acid could have some cytotoxicity related to its abilities to 
interact with membrane, inhibit enzyme activity, and chelate metal 
especially iron. We tested cytotoxicity on NIH3T3 mouse fibroblasts. The 
threshold concentration above which we recorded cytotoxicity is 125 µM 
(representing 200 mg/mL) (Supplementary Figure S3). Considering the 
concentration of tannic acid released over time, we are in a range that is 
not toxic for eukaryotic cells. However, further in vitro testing is 
mandatory before testing such material in vivo in clinical condition such 
as wound closure model. 
The easy handling of this porous material to give it various shapes and 
sizes is promising for future use. Indeed, applications could be found in 
the preparation of wound dressings with anti-microbial properties. The 
material can be manipulated with tweezers and can then be put in contact 
with a wound and comply with the actual protocol of wound dressing. 
Research tends to avoid the use of antibiotics to diminish the appearance 
of bacterial resistance. For example, we can cite the use of silver 
derivatives in various materials such as cellulose or carrageenan-based 
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hydrogels [26,27]. Such cost-effective antimicrobial agents delivering 
matrices could also be used in periodontology. Indeed, adjuvant therapy 
to scaling and root planning therapy using a degradable material loaded 
with chlorhexidine inserted in periodontal pockets is already available in 
the clinic (Periochip®) [28,29]. The material designed herein could be an 
alternative in the case of chlorhexidine allergy.  
CONCLUSIONS 
Herein, we show an easy and cost-effective way to prepare a porous 
material that can be used to locally deliver tannic acid. Conserved as 
lyophilized, tannic acid keeps its activity and has been proved to be 
antimicrobial against S. aureus and E. coli once released into the 
surrounding media after matrix hydration. The content of tannic acid can 
be modulated easily, and thus also the concentration of tannic acid release. 
It is thus suitable to fight various bacteria even if their sensibility to tannic 
acid varies. The method allows producing matrices with various shapes 
and sizes. It therefore could be used in different applications from wound 
dressing to periodontology.  
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